Drug information for LITHOBID

Form	Dosage	Status	Therapeutic Equivalence	Active Ingred	Ref.	Sponsor	Document
TABLET, EXTENDED RELEASE; ORAL	300MG	Prescription	AB (Reference Drug)	LITHIUM CARBONATE	Lithium Carbonate	NOVEN THERAP	18027 2011-10-25 Label 2011-10-24 Letter 2008-04-02 Review 2006-10-05 Letter 2006-04-13 Letter 2002-10-07 Letter 2002-10-07 Letter 2002-10-07 Letter 2002-10-07 Label 2002-10-07 Label 2002-10-07 Label

Drug Adverse Effects information for LITHOBID

Role code	Indications	Reaction	# Reports
C	BIPOLAR DISORDER	ALANINE AMINOTRANSFERASE INCREASED	1
C	BIPOLAR DISORDER	ASPARTATE AMINOTRANSFERASE INCREASED	1
C	BIPOLAR DISORDER	BLOOD ALBUMIN DECREASED	1
C	BIPOLAR DISORDER	BLOOD ALKALINE PHOSPHATASE INCREASED	1
C	BIPOLAR DISORDER	DELIRIUM	1
C	BIPOLAR DISORDER	FATIGUE	1
C	BIPOLAR DISORDER	HIP SURGERY	1
C	BIPOLAR DISORDER	HYPOTHYROIDISM	1
C	BIPOLAR DISORDER	IMPAIRED WORK ABILITY	1
C	BIPOLAR DISORDER	KNEE ARTHROPLASTY	1
C	BIPOLAR DISORDER	MYELODYSPLASTIC SYNDROME	1
C	BIPOLAR DISORDER	NEPHROPATHY	1
C	BIPOLAR DISORDER	OFF LABEL USE	1
C	DEPRESSION	AGITATION	2
C	DEPRESSION	ANXIETY	2
C	DEPRESSION	SUICIDAL IDEATION	2
C	NAUSEA	ALANINE AMINOTRANSFERASE INCREASED	1
C	NAUSEA	ASPARTATE AMINOTRANSFERASE INCREASED	1
C	NAUSEA	BLOOD ALBUMIN DECREASED	1
C	NAUSEA	BLOOD ALKALINE PHOSPHATASE INCREASED	1
C	NAUSEA	DELIRIUM	1
C	NAUSEA	HIP SURGERY	1
C	NAUSEA	KNEE ARTHROPLASTY	1
C	NAUSEA	MYELODYSPLASTIC SYNDROME	1
C	NAUSEA	OFF LABEL USE	1
C	SCHIZOAFFECTIVE DISORDER	TARDIVE DYSKINESIA	1

Ads by Google